These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15637794)

  • 21. Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey.
    Goehringer F; Bonnet F; Salmon D; Cacoub P; Paye A; Chêne G; Morlat P; May T
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):187-193. PubMed ID: 27981873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy].
    Sodqi M; Marih L; Lahsen AO; Bensghir R; Chakib A; Himmich H; El Filali KM
    Presse Med; 2012 Jul; 41(7-8):e386-90. PubMed ID: 22350063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Int J STD AIDS; 2005 Jan; 16(1):42-8. PubMed ID: 15705272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
    Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
    Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
    Salmon-Ceron D; Lewden C; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
    J Hepatol; 2005 Jun; 42(6):799-805. PubMed ID: 15973779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
    Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
    Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011.
    Cowell A; Shenoi SV; Kyriakides TC; Friedland G; Barakat LA
    J Hosp Med; 2015 Sep; 10(9):608-14. PubMed ID: 26130520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
    Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
    Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
    Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
    Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.
    Garriga C; García de Olalla P; Miró JM; Ocaña I; Knobel H; Barberá MJ; Humet V; Domingo P; Gatell JM; Ribera E; Gurguí M; Marco A; Caylà JA;
    PLoS One; 2015; 10(12):e0145701. PubMed ID: 26716982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause of death among HIV patients in London in 2016.
    Croxford S; Miller RF; Post FA; Harding R; Lucas SB; Figueroa J; Harrison I; Delpech VC; Dhoot S; Sullivan AK
    HIV Med; 2019 Oct; 20(9):628-633. PubMed ID: 31274241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining Mortality to Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center.
    Ressler AM; Abdo M; MaWhinney S; Johnson SC; Erlandson KM
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1082-1088. PubMed ID: 31432692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Trends in mortality and causes of death among persons with HIV infection, 1985-2004].
    Aldaz P; Castilla J; Moreno-Iribas C; Irisarri F; Floristán Y; Sola-Boneta J; Martínez-Artola V; Fernández-Jaúregui C; Dorronsoro I
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):5-10. PubMed ID: 17261240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
    Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
    Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
    BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.
    Sackoff JE; Hanna DB; Pfeiffer MR; Torian LV
    Ann Intern Med; 2006 Sep; 145(6):397-406. PubMed ID: 16983127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.
    Haydon GH; Flegg PJ; Blair CS; Brettle RP; Burns SM; Hayes PC
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):485-9. PubMed ID: 9855064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.